VOLORIDGE INVESTMENT MANAGEMENT, LLC - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,884,000
-68.0%
265,365
-67.5%
0.01%
-69.7%
Q1 2022$5,886,000
-43.5%
815,277
-30.0%
0.03%
-42.1%
Q4 2021$10,410,000
+15.3%
1,164,467
+352.4%
0.06%
-1.7%
Q3 2021$9,025,000
+50.9%
257,416
-7.6%
0.06%
+41.5%
Q2 2021$5,981,000278,4500.04%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$3,780,00035.90%
BML Capital Management, LLC 4,800,000$14,400,00013.22%
Stonepine Capital Management, LLC 1,720,000$5,160,0001.71%
TANG CAPITAL MANAGEMENT LLC 3,600,000$10,800,0001.52%
CM Management, LLC 275,000$825,0000.88%
Bain Capital Life Sciences Investors, LLC 2,485,638$7,456,9140.83%
EcoR1 Capital, LLC 6,995,861$20,987,5830.71%
SECTORAL ASSET MANAGEMENT INC 600,461$1,801,3830.35%
Newtyn Management, LLC 400,000$1,200,0000.30%
Diametric Capital, LP 200,000$600,0000.25%
View complete list of ATEA PHARMACEUTICALS INC shareholders